Patricia J Pietrobon

Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial.

R. Gesser, M. van Cleeff, G. de Bruyn, 2016, Vaccine.